Lineage reprogramming to induced cardiac progenitor cells (iCPC) by defined factors
Animal cells, notably adult fibroblasts, are advantageously reprogrammed in direct lineage reprogramming methods using defined factors to produce proliferative and multipotent induced cardiac progenitor cells (iCPC). The iCPC thus produced can be differentiated under suitable differentiation conditions to cardiac lineage cells including cardiomyocytes, smooth muscle cells, and endothelial cells, as evidenced by expression of lineage specific markers. Sets of factors effective in combination to reprogram the fibroblasts can include a set that includes some or all of 5 factors (Mesp1, Baf60c, Nkx2.5, Gata4, Tbx5), a set that includes some or all of 11 factors (Mesp1, Mesp2, Gata4, Gata6, Baf60c, SRF, Isl1, Nkx2.5, Irx4, Tbx5, Tbx20), a set that includes some or all of 18 factors (T, Mesp1, Mesp2, Tbx5, Tbx20, Isl1, Gata4, Gata6, Irx4, Nkx2.5, Hand1, Hand2, Tbx20, Tbx18, Tip60, Baf60c, SRF, Hey2), and a set that includes some or all of 22 factors (T, Mesp1, Mesp2, Tbx5, Tbx20, Isl1, Gata4, Gata6, Irx4, Nkx2.5, Hand1, Hand2, Tbx20, Tbx18, Tip60, Baf60c, SRF, Hey2, Oct4, Klf4, Sox2, L-myc).
1. An isolated induced cardiac progenitor cell (iCPC) comprising one or more vectors encoding Mesp1, Baf60c, Nkx2.5, Gata4, Tbx5, Mesp2, Gata6, SRF, Isl1, Irx4, and Tbx20, wherein the isolated iCPC is capable of differentiating into cardiomyocytes, SM-MHC + smooth muscle cells, and CD31 + endothelial cells,
wherein the iCPC is capable of proliferating and remaining multipotent for at least 5 passages in a culture medium comprising an activator of canonical Wnt signaling and an activator of Jak/Stat signaling, and wherein the iCPC is NKx2.5+, Gata4+, Irx4+, Cxcr4+, Oct4−, Mlc-2a−, SM-MHC−, and CD31−.
2. An in vitro cell culture comprising:
an NKx2.5 + , Gata4 + , Irx4 + , Cxcr4 + , Oct4 − , Mlc-2a − , SM-MHC − , and CD31 − induced cardiac progenitor cell (iCPC) population capable of differentiating into cardiomyocytes, SM-MHC + smooth muscle cells, and CD31 + endothelial cells, wherein the iCPC population comprises iCPCs comprising one or more vectors encoding Mesp1, Baf60c, Nkx2.5, Gata4, Tbx5, Mesp2, Gata6, SRF, Isl1, Irx4, and Tbx20; and
a cell culture medium comprising an activator of canonical Wnt signaling in an amount sufficient to maintain proliferation and multipotency of the iCPCs in the iCPC population for at least 5 passages.
3. The isolated induced cardiac progenitor cell of claim 1 , wherein the one or more vectors further encode factors T, Hand1, Hand2, Tbx18, Tip60, SRF, Hey2, Oct4, Klf4, Sox2, and L-myc.
4. The in vitro cell culture of claim 2 , wherein the activator of canonical Wnt signaling is BIO.
5. The in vitro cell culture of claim 2 , wherein the cell culture medium further comprises an activator of Jak/Stat signaling.
6. The in vitro cell culture of claim 5 , wherein the activator of Jak/Stat signaling is selected from the group consisting of Leukemia Inhibitory Factor (LIF), IL-2, IL-6, IL-11, leptin, and ciliary neurotrophic factor (CNTF).
7. The isolated induced cardiac progenitor cell population of claim 1 , wherein the one or more vectors are selected from the group consisting of a viral vector, a non-viral episomal vector, a liposome, a polymer-nucleic acid complex, and a peptide-nucleic acid complex.